HER2-Positive Early Stage Breast Cancer
Also known as: HER2-positive early-stage breast cancer / Early Stage HER2+ Breast Cancer / HER2-Positive Early Breast Cancer
Drug | Drug Name | Drug Description |
---|---|---|
DB05773 | Trastuzumab emtansine | An antineoplastic agent and antibody-drug conjugate used to treat HER2-overexpressing breast cancer. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB05773 | Trastuzumab emtansine | Receptor tyrosine-protein kinase erbB-2 | target |
DB05773 | Trastuzumab emtansine | P-glycoprotein 1 | transporter |
DB05773 | Trastuzumab emtansine | Cytochrome P450 3A4 | enzyme |
DB05773 | Trastuzumab emtansine | Cytochrome P450 3A5 | enzyme |